Skip to Content
Morningstar

Russell Inv Equity Income S RLISX

Morningstar Medalist Rating
Medalist Rating as of | See Russell Investments Investment Hub
  • NAV / 1-Day Return 24.77  /  +0.81 %
  • Total Assets 187.5 Mil
  • Adj. Expense Ratio
    0.830%
  • Expense Ratio 0.830%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment —
  • Status Open
  • TTM Yield 1.53%
  • Turnover 31%

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 12:06 AM GMT+0

Morningstar’s Analysis RLISX

Will RLISX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable RLISX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the RLISX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of RLISX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Weakness in Russell Inv Equity Income S's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RLISX

More RLISX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 19.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

E-mini S&P 500 Future June 24

4.61 9.6 Mil
—

U.S. Cash Management Fund

4.40 9.1 Mil
Cash and Equivalents

JPMorgan Chase & Co

2.35 4.9 Mil
Financial Services

Berkshire Hathaway Inc Class B

2.00 4.1 Mil
Financial Services

CVS Health Corp

1.93 4.0 Mil
Healthcare

Wells Fargo & Co

1.63 3.4 Mil
Financial Services

Merck & Co Inc

1.57 3.2 Mil
Healthcare

Citigroup Inc

1.56 3.2 Mil
Financial Services

Johnson & Johnson

1.35 2.8 Mil
Healthcare

Medtronic PLC

1.32 2.7 Mil
Healthcare